Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001019056-25-000081
Filing Date
2025-02-11
Accepted
2025-02-11 19:09:02
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 12221
  Complete submission text file 0001019056-25-000081.txt   14149
Mailing Address 207 CALLE DEL PARQUE A&M TOWER 8TH FLOOR SAN JUAN PR 00912
Business Address 207 CALLE DEL PARQUE A&M TOWER 8TH FLOOR SAN JUAN PR 00912 864-990-3233
Long Focus Capital Management, LLC (Filed by) CIK: 0001602716 (see all company filings)

EIN.: 462772035 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A

Mailing Address 260 SHERIDAN AVENUE SUITE 400 PALO ALTO CA 94306
Business Address 260 SHERIDAN AVENUE SUITE 400 PALO ALTO CA 94306 650-800-6676
Vincerx Pharma, Inc. (Subject) CIK: 0001796129 (see all company filings)

EIN.: 833197402 | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-91457 | Film No.: 25611408
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)